Establishment Labs Holdings Net Income
| ESTA Stock | USD 71.66 0.92 1.27% |
As of the 11th of February 2026, Establishment Labs shows the Coefficient Of Variation of 977.54, mean deviation of 2.46, and Downside Deviation of 3.28. Establishment Labs technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Establishment Labs Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 11.5741 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -67.7 M | -64.3 M | |
| Net Loss | -76.1 M | -79.9 M | |
| Net Loss | -76.1 M | -72.3 M | |
| Net Loss | (3.45) | (3.63) | |
| Net Income Per E B T | 0.90 | 0.81 |
Establishment | Net Income | Build AI portfolio with Establishment Stock |
Analyzing Establishment Labs's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Establishment Labs's current valuation and future prospects.
Latest Establishment Labs' Net Income Growth Pattern
Below is the plot of the Net Income of Establishment Labs Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Establishment Labs financial statement analysis. It represents the amount of money remaining after all of Establishment Labs Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Establishment Labs' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (84.6 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Establishment Net Income Regression Statistics
| Arithmetic Mean | (34,817,705) | |
| Coefficient Of Variation | (91.29) | |
| Mean Deviation | 26,555,369 | |
| Median | (34,897,000) | |
| Standard Deviation | 31,785,777 | |
| Sample Variance | 1010.3T | |
| Range | 83M | |
| R-Value | (0.94) | |
| Mean Square Error | 121.9T | |
| R-Squared | 0.89 | |
| Slope | (5,927,709) | |
| Total Sum of Squares | 16165.4T |
Establishment Net Income History
Other Fundumenentals of Establishment Labs
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Establishment Labs Net Income component correlations
Establishment Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Establishment Labs is extremely important. It helps to project a fair market value of Establishment Stock properly, considering its historical fundamentals such as Net Income. Since Establishment Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Establishment Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Establishment Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. Projected growth potential of Establishment fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Establishment Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.97) | Revenue Per Share | Quarterly Revenue Growth 0.337 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Establishment Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Establishment Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Establishment Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Establishment Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Establishment Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Establishment Labs.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Establishment Labs on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Establishment Labs Holdings or generate 0.0% return on investment in Establishment Labs over 90 days. Establishment Labs is related to or competes with CONMED, Azenta, UFP Technologies, Novocure, Zymeworks Common, Kestra Medical, and Adapthealth Corp. Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic a... More
Establishment Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Establishment Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Establishment Labs Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.28 | |||
| Information Ratio | 0.0733 | |||
| Maximum Drawdown | 14.96 | |||
| Value At Risk | (5.74) | |||
| Potential Upside | 4.55 |
Establishment Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Establishment Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Establishment Labs' standard deviation. In reality, there are many statistical measures that can use Establishment Labs historical prices to predict the future Establishment Labs' volatility.| Risk Adjusted Performance | 0.0894 | |||
| Jensen Alpha | 0.268 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0712 | |||
| Treynor Ratio | 0.5405 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Establishment Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Establishment Labs February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0894 | |||
| Market Risk Adjusted Performance | 0.5505 | |||
| Mean Deviation | 2.46 | |||
| Semi Deviation | 3.02 | |||
| Downside Deviation | 3.28 | |||
| Coefficient Of Variation | 977.54 | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.18 | |||
| Information Ratio | 0.0733 | |||
| Jensen Alpha | 0.268 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0712 | |||
| Treynor Ratio | 0.5405 | |||
| Maximum Drawdown | 14.96 | |||
| Value At Risk | (5.74) | |||
| Potential Upside | 4.55 | |||
| Downside Variance | 10.77 | |||
| Semi Variance | 9.13 | |||
| Expected Short fall | (2.70) | |||
| Skewness | (0.35) | |||
| Kurtosis | 0.1027 |
Establishment Labs Backtested Returns
Establishment Labs appears to be very steady, given 3 months investment horizon. Establishment Labs secures Sharpe Ratio (or Efficiency) of 0.0784, which denotes the company had a 0.0784 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Establishment Labs Holdings, which you can use to evaluate the volatility of the firm. Please utilize Establishment Labs' Downside Deviation of 3.28, mean deviation of 2.46, and Coefficient Of Variation of 977.54 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Establishment Labs holds a performance score of 6. The firm shows a Beta (market volatility) of 0.59, which means possible diversification benefits within a given portfolio. As returns on the market increase, Establishment Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Establishment Labs is expected to be smaller as well. Please check Establishment Labs' semi variance, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Establishment Labs' price patterns will revert.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Establishment Labs Holdings has insignificant reverse predictability. Overlapping area represents the amount of predictability between Establishment Labs time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Establishment Labs price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Establishment Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 7.26 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Establishment Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Establishment Labs Holdings reported net income of (84.6 Million). This is 124.79% lower than that of the Health Care Equipment & Supplies sector and 135.53% lower than that of the Health Care industry. The net income for all United States stocks is 114.82% higher than that of the company.
Establishment Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Establishment Labs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Establishment Labs could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics of similar companies.Establishment Labs is currently under evaluation in net income category among its peers.
Establishment Labs Current Valuation Drivers
We derive many important indicators used in calculating different scores of Establishment Labs from analyzing Establishment Labs' financial statements. These drivers represent accounts that assess Establishment Labs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Establishment Labs' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 877.6M | 1.6B | 1.6B | 662.8M | 596.5M | 706.4M | |
| Enterprise Value | 845.6M | 1.6B | 1.7B | 815.0M | 733.5M | 732.4M |
Establishment Labs ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Establishment Labs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Establishment Labs' managers, analysts, and investors.Environmental | Governance | Social |
Establishment Labs Institutional Holders
Institutional Holdings refers to the ownership stake in Establishment Labs that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Establishment Labs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Establishment Labs' value.| Shares | Mudita Advisors Llp | 2025-06-30 | 600.7 K | The Toronto-dominion Bank | 2025-06-30 | 540 K | Boothbay Fund Management, Llc | 2025-06-30 | 537.5 K | Balyasny Asset Management Llc | 2025-06-30 | 488.7 K | First Light Asset Management, Llc | 2025-06-30 | 417.2 K | Royce & Associates, Lp | 2025-06-30 | 400.5 K | Centerbook Partners Lp | 2025-06-30 | 379.4 K | Jpmorgan Chase & Co | 2025-06-30 | 373.1 K | Viking Global Investors Lp | 2025-06-30 | 343.5 K | Jw Asset Management, Llc | 2025-06-30 | 3.1 M | Rtw Investments, Llc | 2025-06-30 | 2.6 M |
Establishment Fundamentals
| Return On Equity | -3.38 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 2.21 B | ||||
| Shares Outstanding | 29.06 M | ||||
| Shares Owned By Insiders | 17.55 % | ||||
| Shares Owned By Institutions | 82.45 % | ||||
| Number Of Shares Shorted | 4.53 M | ||||
| Price To Earning | (20.11) X | ||||
| Price To Book | 123.44 X | ||||
| Price To Sales | 11.04 X | ||||
| Revenue | 166.03 M | ||||
| Gross Profit | 131.27 M | ||||
| EBITDA | (56.22 M) | ||||
| Net Income | (84.6 M) | ||||
| Cash And Equivalents | 65.35 M | ||||
| Cash Per Share | 2.68 X | ||||
| Total Debt | 225.29 M | ||||
| Current Ratio | 4.27 X | ||||
| Book Value Per Share | 0.56 X | ||||
| Cash Flow From Operations | (58.52 M) | ||||
| Short Ratio | 8.51 X | ||||
| Earnings Per Share | (2.97) X | ||||
| Target Price | 83.25 | ||||
| Number Of Employees | 1.02 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 2.11 B | ||||
| Total Asset | 346.83 M | ||||
| Retained Earnings | (444.69 M) | ||||
| Working Capital | 174.76 M | ||||
| Current Asset | 60.91 M | ||||
| Current Liabilities | 45.78 M | ||||
| Net Asset | 346.83 M |
About Establishment Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Establishment Labs Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Establishment Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Establishment Labs Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:Check out You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. Projected growth potential of Establishment fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Establishment Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.97) | Revenue Per Share | Quarterly Revenue Growth 0.337 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Establishment Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Establishment Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Establishment Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.